Background: It has been hypothesized that serum lipids measured in the early period of stroke are predictive of stroke severity and outcome. The optimal time for lipid measurement is not established. We explored whether lipid profile assessed within the first 24 h after stroke onset: (i) differs from that in stroke-free individuals; (ii) differs between stroke subtypes; and (iii) is predictive of stroke severity and outcome. Methods: We prospectively enrolled 70 acute ischemic stroke patients who presented to the Stroke Unit within 24 h of the onset of stroke symptoms, and 68 stroke-free control subjects. Results: Triglycerides (p-0.001) and high-density lipoprotein (HDL) cholesterol (p-0.001) were significantly lower in patients than in controls. HDL cholesterol was different across stroke subtypes classified according to the Trial of ORG 10172 in Acute Stroke Treatment scale (ps0.035). Patients with more severe stroke had higher serum triglycerides (odds ratio 2.755; ps0.030). Conclusions: Serum triglycerides might serve as a prognostic marker in acute stroke patients.
levels measured in the early period after stroke admission are predictive of infarct volume and 6-month mortality (5), brain infarction subtype (6) and early death from stroke (7) .
Nevertheless, there is no widely accepted recommendation on the optimal time for lipid measurement. Studies on lipid concentrations measured during the early acute period of brain ischemia have produced conflicting results so far (8, 9) .
We aimed to determine whether a lipid profile assessed within the first 24 h after stroke onset: (i) differs from that in stroke-free control individuals; (ii) differs between stroke subtypes; and (iii) is predictive of stroke severity and outcome.
We performed a prospective observational study of patients who presented with acute ischemic stroke to the Emergency Department of the Neurology Clinic at the tertiary care teaching University Hospital Sestre milosrdnice within 24 h of the onset of stroke symptoms. Patient recruitment lasted from September 2005 to February 2006. Stroke diagnosis was made upon clinical examination and computed tomography (CT) scan results. Exclusion criteria were hemorrhagic stroke, stroke with symptoms lasting longer than 24 h and transitory ischemic attack (TIA). We also excluded cases for whom the time of onset of stroke symptoms was not clear.
For comparison of lipid profiles, we also enrolled a group of stroke-free control individuals who had some stroke risk factors. This group consisted of hospital staff who self-reported their health status and were free of any obvious acute disease. Exclusion criteria were personal history of stroke or TIA. Individuals who reported that they were on statin therapy were not included in the study.
Fasting blood samples were drawn within 24 h of admission for triglycerides, cholesterol, high-density lipoprotein (HDL)-cholesterol, low-density lipoprotein (LDL)-cholesterol, apolipoprotein (apo)A-I and apoB. Blood was allowed to clot and then centrifuged at 3,500 rpm (3000 g) for 10 min. Sera were collected and assayed immediately. All biochemical tests were performed on the same day using Olympus reagents on an automated analyzer (Olympus AU-2700, Tokyo, Japan). The apoB/apoA-I ratio was calculated. Data on age, sex, smoking status, body mass index (BMI), diabetes mellitus, hypertension, presence of atrial fibrillation and personal history of acute myocardial infarction were collected from each patient. Smoking status was defined as either current smoker or nonsmoker.
Stroke type was determined according to two different sets of classification criteria: Oxfordshire Community Stroke Project clinical classification (OCSP) (10) and Trial of ORG 10172 in Acute Stroke Treatment (TOAST) (11) . Stroke classification was assessed by a neurologist on admission. Based on the TOAST criteria, subjects were divided into the following five clinical categories: large-artery atherosclerosis, cardioembolic stroke, small-artery occlusion, stroke of other determined etiology, or stroke of undetermined etiology. Based on the OCSP (Oxfordshire Community Stroke Project) criteria, subjects were divided into the following four clinical categories: total anterior circulation infarct (TACI), partial anterior circulation infarct (PACI), lacunar infarct (LACI), and posterior circulation infarct (POCI). Patient neurological deficit was assessed using the National Institutes of Health Stroke Scale (NIHSS) scoring system on admission while the patient was still in the emergency room. The Barthel index (BI) scale was used to measure the degree of disability on patient discharge. The study protocol was approved by the appropriate institutional Ethics Committee and all patients (or their first-degree relatives) consented to enter the study.
All descriptive categorical data are presented as mean and percentage. Age is presented as median and interquartile range. The distribution of each continuous quantitative variable was explored for normality using the Kolmogorov-Smirnov test. Normally distributed variables are presented as mean"standard deviation, and a parametric statistical test (Student's t-test) was applied to test for possible differences between groups. Non-normally distributed variables are presented as median and interquartile range, and a non-parametric statistical test (MannWhitney rank sum test) was applied. Differences in categorical variables between groups were assessed using a x 2 test. A parametric ANOVA test was applied to test differences in the concentration of various lipid parameters across different TOAST stroke subgroups. The Kruskal-Wallis test was used to explore the significance of differences in the concentration of various lipid parameters across different OCSP stroke subgroups. Univariate and multivariate linear and logistic regression analyses were performed to explore the possible predictive value of various parameters.
The study had 80% power to detect a mean difference of 5% in serum concentration of lipid parameters between different stroke subtypes at the level of less than 0.05 statistical significance. Statistical analysis was performed using MedCalc ᮋ statistical software (MedCalc 9.3.9.0, Frank Schoonjans, Mariakerke, Belgium).
We studied 70 patients hospitalized for CT-confirmed acute ischemic stroke and 68 disease-free controls. The baseline demographic characteristics of the control subjects and stroke patients are summarized in Table 1 . Stroke patients were older (p-0.001) and male gender was more prevalent in cases (ps0.008) compared to controls. Interestingly, smoking (p-0.001) and obesity (ps0.001) were more prevalent in stroke-free control individuals. The distribution of other conventional vascular risk factors did not differ between our stroke cases and controls.
Lipid profiles were compared between cases and controls ( Table 2 ). Triglycerides wodds ratio (OR) 0.103, confidence interval (CI) 0.042-0.249; p-0.001x and HDL cholesterol (OR 0.0339, CI 0.012-0.100; p-0.001) were significantly lower in patients than in controls, whereas apoB/A-1 ratio was higher in patients (OR 4.535, CI 1.171-21.186; ps0.019). All observed differences remained significant after adjusting for age, sex and BMI. Other lipid parameters did not differ between stroke cases and controls.
We tested the correlation of all stroke risk factors with (a) the severity of the clinical status and (b) the value of the lipid parameters. There was no significant correlation for any of the relationships studied (data not shown).
A total cohort of 70 stroke patients was classified using TOAST stroke classification criteria ( Table 2) . The most frequent type of stroke was cardioembolic stroke (ns25), followed by large-artery atherosclerosis (ns18). The less frequent types were strokes of other determined (ns5) or undetermined causes (ns6).
The concentration of serum HDL-cholesterol was different across stroke subtypes classified according to the TOAST scale (ps0.035). Serum HDL-concentrations were highest in the stroke subgroup of undetermined etiology and lowest in the subgroup of other determined causes of stroke. Other lipid parameters did not differ significantly across various TOAST subgroups.
Stroke patients were also classified using OCSP stroke classification criteria ( Table 3 ). The most frequent type of stroke was PACI (ns31); LACI was present in 26 stroke patients, whereas POCI (ns8) and TACI (ns3) were underrepresented in our stroke Table 2 Lipid profiles for control subjects, stroke patients and TOAST stroke subtypes. LAA, large-artery athersclerosis; CES, cardioembolic stroke; SAO, small-artery occlusion; ODE, strokes of other determined etiology; SUE, strokes of undetermined etiology.
group. Patient lipid profiles did not differ significantly across the four OCSP stroke subtypes.
The stroke cohort was divided into two groups according to their NIHSS score (Table 4) : the group of patients experiencing moderate neurological deficit with NIHSS score F16 and of patients suffering from substantial neurological deficit with NIHSS score )16. Serum concentrations of triglycerides differed significantly between patients with different stroke severity. Patients with more severe stroke had higher serum triglycerides (OR 2.755, CI 1.0540-7.2027; ps0.030). Patient demographic characteristics and conventional vascular risk factors were not predictive of stroke severity (data not shown).
Patient lipid profiles were also analyzed with regard to BI ( Table 4 ). The stroke cohort was divided into two groups according to their BI score: those with a high degree of disability with BIF15 and those with a moderate to low degree of disability with BI) 15 . No difference in lipid profiles was found between these two groups divided according to BI score.
The major finding of our study is that higher serum triglycerides are associated with more severe stroke and substantial neurological deficit. Other lipid parameters did not vary in terms of stroke severity and outcome. We also observed significantly lower concentrations of triglycerides and HDL-cholesterol and higher apoB/apoA-I ratio in patients compared to disease-free control subjects.
It is well established that concentrations of serum cholesterol decrease after acute myocardial infarction, reaching lowest levels within the first week after ischemic attack (12) . Cholesterol levels measured in the first 24 h after myocardial infarction most probably reflect premorbid patient values. It is therefore recommended that patients with acute myocardial infarction should have serum lipids determined within 24 h of the onset of ischemic attack (13) for risk assessment and proper management of hypercholesterolemia.
Several investigators have studied changes in lipid profile in acute stroke patients. Lipid concentrations were mostly lower in the early period after stroke, but there are also some reports on elevated lipids in early stroke. Woo et al. reported an initial increase in cholesterol, LDL-cholesterol and apoB concentrations, whereas serum triglycerides and lipoprotein(a) were low (14) . They concluded that lipid measurements carried out -48 h after ictus do not provide reliable evidence for identifying patients who would benefit more from lipid-lowering agents. Vukasovic et al. observed lowest triglyceride concentrations in the TACI stroke subgroup (15) .
In one of our previous studies, total serum cholesterol and HDL-cholesterol concentrations measured within 24 h of stroke onset were lower in acute stroke patients compared to disease-free controls (16) . We might speculate that lower cholesterol is due to the sudden decrease caused by acute cerebral ischemia and acute inflammatory reaction. Different study designs with patient follow-up after stroke are needed to prove this hypothesis. There is a possibility that the difference observed in triglyceride concentrations might be biased, since triglyceride concentrations in our control subjects were much higher than those recommended by the National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) III. It has been confirmed in several independent studies that lipid parameters in healthy Croatian subjects are much higher than those recommended by NCEP-ATPIII (17, 18) .
Laloux et al. investigated lipid changes in acute ischemic stroke patients within 2 days after stroke onset (19) . Stroke patients in their study had higher levels of total cholesterol and triglycerides and lower HDL-cholesterol. When they compared plasma lipid profiles across different stroke subtypes, only HDLcholesterol differed between small-vessel and largevessel disease, suggesting a different role of HDL in the etiology of different stroke subtypes.
In another study on cerebral infarction patients, serum total cholesterol and LDL-cholesterol concentrations were intermediate on day 1, lowest on day 7, and highest at 3 months, whereas changes in very low density lipoprotein (VLDL)-cholesterol and HDLcholesterol were of minor significance (20) . The authors concluded that important lipoprotein abnormalities may be missed if lipid profiles are assessed in the acute phase of stroke.
Stroke is a heterogeneous disease of various etiological origins. Lipid status is therefore rather different in different stroke subtypes. This may be at least partially the reason for so many conflicting and inconsistent results on lipid profile changes in acute stroke. The prognostic significance of blood lipids should therefore be assessed in specific stroke subtypes. Unfortunately, the small size of the stroke subgroups in the present study did not allow such an analysis. It should also be mentioned that the relatively small size of stroke subgroups divided according to NIHSS scores and BI scores are possible limitations of this study and may have influenced our results. Our results should therefore be taken with caution and confirmed in a larger patient group. Based on these preliminary data, we are planning to undertake another such study on a much larger patient cohort to examine the replicability of our results.
What is also lacking in all studies published so far is knowledge of premorbid baseline lipid levels. Unfortunately, information on lipid levels measured immediately before stroke is practically impossible to obtain. However, it has been hypothesized that after more or less profound fluctuations in the acute period after stroke, lipid levels return to their putative baseline values, which are most probably comparable to those before stroke.
The exact mechanism involved in lipid changes in acute ischemia remains unclear. However, it is known that acute dyslipidemia is a consequence of stress and systemic inflammatory and endocrine changes, followed by increased catecholamine blood levels, which may be part of the mechanism involved.
We conclude that lipid profiles differ between stroke patients and disease-free individuals and between stroke subtypes. Furthermore, higher serum concentrations of triglycerides are associated with more severe stroke and substantial neurological deficit. Further work is required to examine in more detail the time-dependent changes in lipid profile in acute ischemic stroke. If proven to have some predictive role for a larger patient cohort, blood lipid profiles may serve as useful aid in the management of acute stroke patients. Further prospective longitudinal studies are needed to define the best time for lipid meas-urement in acute stroke patients with the aim of initiating lipid-lowering therapy.
